Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients

Table 1

Demographic characteristics of the investigated patients.

	Total ()	Survivor ()	Nonsurvivor ()
Age, years ()				0.004
Male (, %)	40 (75%)	15 (71%)	25 (78%)	0.307
Comorbidities (, %)
Diabetes mellitus	19 (35.8%)	4 (19%)	15 (46%)	0.022
Dyslipidemia	14 (26.4%)	6 (28.5%)	8 (25%)	0.412
Hypertension	14 (26.4%)	6 (28.5%)	8 (25%)	0.361
Chronic pulmonary disease	6 (11.3%)	2 (9.5%)	4 (12.5%)	0.284
Chronic renal failure	2 (3.7%)	1 (4.7%)	1 (3.1%)	0.521
Sepsis origin (, %)
Pulmonary	31 (58.4%)	14 (66.5%)	17 (53%)	0.491
Abdominal	1 (1.8%)	1 (4.7%)	0 (0%)
Central venous catheter	3 (5.6%)	1 (4.7%)	2 (6.2%)
Urinary tract	7 (13.2%)	3 (14.2%)	4 (12.5%)
Skin and soft tissue	6 (11.3%)	2 (9.5%)	4 (12.5%)
Nonidentified	5 (9.4%)	2 (9.5%)	3 (9.3%)
Septic shock (, %)	29 (54.7%)	7 (33%)	22 (69%)	0.012
Thrombotic events (, %)	11 (20.75%)	7 (33%)	4 (12.5%)	0.067
Length of stay				0.081
SOFA ()
Baseline				0.642
Day 1				0.221
Day 3				0.001
Day 5				0.002
Day 8				0.364
Day 10				0.210
Mortality (%)	60

SOFA: Sequential Organ Failure Assessment score; SD: standard deviation.